SynBioBeta Speaker

Jonas Sandbrink

Sentinel Bio

Entrepreneur-in-Residence

Jonas is an Entrepreneur-in-Residence at Sentinel Bio, where he is building BioTrust: a verified researcher credential for accessing bio-capable AI models. Researchers verify once, and get trusted across providers. Previously, he worked at the UK AI Security Institute, where he founded and built the chemical and biological evaluations program, which informed frontier AI labs model deployments. Later, he led AISI’s Strategic Awareness work to increase government understanding and preparedness for advanced AI capabilities. Before joining the AI Security Institute, he researched synthetic biology and AI biosecurity risks at the University of Oxford, and advised the UK Cabinet Office, Google DeepMind, and the Nuclear Threat Initiative.Jonas holds a PhD from Oxford's Nuffield Department of Medicine, where his interdisciplinary work combined scientific risk assessment, policy analysis, and ethics to examine misuse risks from synthetic virology and AI.

Sessions Featuring

Jonas

This Year

Breakout Session

•

4:30 PM

-

5:15 PM

Business of Biology

Synthesis Screening in the Age of Powerful AI

As AI reshapes what's possible in biology, biosecurity needs to keep up. Nucleic acid synthesis screening, which checks what's being ordered and by whom, is one of the field's most important lines of defense. But as AI capabilities advance, the screening infrastructure needs to evolve with them. This panel brings together leaders from the Sequence Biosecurity Risk Consortium, Fourth Eon Bio, SecureDNA, and BioTrust to discuss how sequence and customer screening are adapting to a new threat landscape.

Featuring

Jacob Beal

RTX BBN Technologies

Engineering Fellow

Gary Abel

Fourth Eon Bio

Principal Scientist

Kirsten Engel

SecureDNA

Dir. Strat. Partnerships & Client Rel.

Jonas Sandbrink

Sentinel Bio

Entrepreneur-in-Residence

Tessa Alexanian

IBBIS

Technical Lead

Breakout Session

•

4:30 PM

-

5:15 PM

Business of Biology

Synthesis Screening in the Age of Powerful AI

As AI reshapes what's possible in biology, biosecurity needs to keep up. Nucleic acid synthesis screening, which checks what's being ordered and by whom, is one of the field's most important lines of defense. But as AI capabilities advance, the screening infrastructure needs to evolve with them. This panel brings together leaders from the Sequence Biosecurity Risk Consortium, Fourth Eon Bio, SecureDNA, and BioTrust to discuss how sequence and customer screening are adapting to a new threat landscape.

Featuring

Jacob Beal

RTX BBN Technologies

Engineering Fellow

Gary Abel

Fourth Eon Bio

Principal Scientist

Kirsten Engel

SecureDNA

Dir. Strat. Partnerships & Client Rel.

Jonas Sandbrink

Sentinel Bio

Entrepreneur-in-Residence

Tessa Alexanian

IBBIS

Technical Lead

Previous Speakers Include